Beyond Air price to sales ratio XAIR

Market value divided by revenue over the last twelve months, since 2024.

Today, Oct 23, 2026: 0.3×
2-year median: 2.7×
Against its 2-year history: 0th; percentile: 0 is its lowest day, 100 its highest
2-year range: 0.3× to 25.1×
Peer median: 0.4×

Beyond Air's price to sales ratio is 0.3× as of Oct 23, 2026.

That is below its 2-year median of 2.7×, lower than on 100% of days in the last 2 years.

Over that time it ranged from 0.3× in Oct 2026 to 25.1× in Jul 2024.

The median for 6 healthcare stocks of a similar size is 0.4×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	0.3×	0.3×	2.3×
2025	1.0×	1.0×	13.4×
2024	13.6×	8.8×	25.1×

Against its peers

Companies in Healthcare nearest Beyond Air's size, closest first, today.

Company	Price to sales ratio
XAIRBeyond Air	0.3×
OXBROXBRIDGE RE HOLDINGS	2.8×
EDUCEducational Development	0.4×
GTIMGood Times Restaurants	0.1×
MDRRMedalist Diversified	1.6×
BCGBinah Capital	0.1×
VIPVulcan Infrastructure & Power	0.4×
Peer median	0.4×

Where Beyond Air ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Beyond Air

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.